cln-081
cullinan oncology,otsuka
['sclc', 'nsclc', 'cln-081 ']
we are thankful for the opportunity to work alongside and connect with others including at #asco22. today we presented our updated clinical research highlighting the potential of cln-081 for patients with egfr exon 20 insertion mutation-positive nsclc. 
Investing in and developing a diversified portfolio of targeted therapies that will dramatically improve the standard-of-care for cancer patients